Accelerated Enrollment Solutions (AES) helps biopharmaceutical and biotechnology companies overcome patient recruitment and research site challenges to deliver greater speed, certainty, and control to clinical trial delivery.
A global clinical trial patient recruitment solution that delivers more patients in less time than the traditional method of relying on disparate clinical trial sites to find and recruit patients.More about AES Patients
AES Sites & Patients is a single global source for clinical trial sites and patients that delivers consistent operations and quality worldwide and more patients from fewer sites in less time.More about AES Sites & Patients
The article discusses the challenges faced by the life sciences industry as a result of the COVID-19 pandemic and how a shift toward technologically driven recruitment is having a positive effect on patient engagement and participation.
This recognition is to our ability to deliver high-quality data, predictable enrollment for vaccine clinical trials and the introduction of new services across our network.
This 90 minute AES sponsored webinar, provides current views from leading experts on the NASH challenges in clinical trials and patient identification. It is free on-demand and available until midnight June 16, 2021 (registration is required).
This video showcases the capabilities of AES in the field of NAFLD & NASH, and how AES is driving clinical development forward into a bright new future by simultaneously solving the challenges of site selection and patient enrollment.
Our teams are the core of the company in promoting our mission, forward-thinking culture and innovation to clinical trial delivery. Find out how you can play a part and make a difference.